期刊文献+

骨化三醇治疗血液透析患者继发性甲状旁腺功能亢进的疗效观察 被引量:8

下载PDF
导出
摘要 目的探讨骨化三醇治疗慢性肾脏病继发性甲状旁腺功能亢进的疗效。方法将92例慢性肾脏病5期血液透析继发性甲状旁腺功能亢进患者随机均分为观察组和对照组,对照组给予骨化三醇常规剂量口服治疗,观察组给予骨化三醇冲击疗法治疗,观察两组患者治疗疗效。结果两组患者治疗前后血钙、血磷水平无显著变化(P>0.05);但治疗后4周、8周血清iPTH水平均明显低于治疗前(P<0.05);观察组患者治疗后4周、8周血清iPTH水平均显著低于同时间对照组水平(P<0.05);观察组患者治疗4周及8周时血清iPTH达标率为69.57%和93.48%,均显著高于对照组的45.65%和80.43%(P<0.05)。结论骨化三醇冲击治疗慢性肾脏病继发性甲状旁腺功能亢进,疗效显著、安全性好,具有较好的应用前景。
作者 蔡璐
出处 《江西医药》 CAS 2014年第6期529-531,共3页 Jiangxi Medical Journal
  • 相关文献

参考文献6

二级参考文献59

  • 1Ito H,Ogata H,Yamamoto M,et al.Comparison of oral falecalcitriol and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism:a randomized,crossover trial[J].Clin Nephrol,2009,71:660-668. 被引量:1
  • 2National Kidney Foundation.K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease[J].Am J Kidney Dis,2003,42:S1-201.K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.Am J Kidney Dis.2003:42(4 Suppl 3):S1-201. 被引量:1
  • 3Levey AS,Coresh J,Balk E.et al.National Kidney Foundation practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].Ann Intern Med,2003,139:137-147. 被引量:1
  • 4Raggi P,Boulay A,Chasan-Taber S,et al.Cardiac calcification in adult hemodialysis patients.A link between end-stage renal disease and cardiovascular disease?[J].J AM COLL Cardiol,2002,39:695-701. 被引量:1
  • 5Andress DL,Norris KC,Coburn JW,et al.Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure[J].N Engl J Med,1989,321:274-279. 被引量:1
  • 6Chan R,Gleun GW,De Vita MV,et al.Effect of oral vs intravenous colcitriol on serum parathyroid hormone levels in chronic hemodialysis patients[J].Nephrol Dial Transplant,1993,22:736-745. 被引量:1
  • 7Borazan A,Ustun H,Cefle A,et al.Comparatire efficacy of oral and intrayenous calcitriol treatment in haemodialysis patients:effects on serum biochemistry and cytokine levels[J].J Int Med Res,2003,31:489-496. 被引量:1
  • 8Tang M,Wolf M,Ofsthun MN,et al.Activated injectable vitamin D and hemodialysis survival:a historical cohort study[J].J Am Soc Nephrol,2005,16:1115-1125. 被引量:1
  • 9E11iott J,Mishier D,Agarwal R.Hyporesponsiveness to erythropoietin:causes and management[J].Adv Chronic Kidney Dis,2009,16:94-100. 被引量:1
  • 10Valderrabano F,Jones EH,Mallick NP.Report on management of renal failure in Europe,XXIV,1993[J].Nephrol Dial Transplant,1995,10 Suppl 5:1-25. 被引量:1

共引文献61

同被引文献53

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部